Literature DB >> 16843184

A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.

Bruce L Wilkoff1, Kevin T Ousdigian, Laurence D Sterns, Zengri J Wang, Ryan D Wilson, John M Morgan.   

Abstract

OBJECTIVES: The purpose of this randomized study was to determine whether a strategically chosen standardized set of programmable settings is at least as effective as physician-tailored choices, as measured by the shock-related morbidity of implantable cardioverter-defibrillator (ICD) therapy.
BACKGROUND: Programming of ventricular tachyarrhythmia (ventricular tachycardia [VT] or ventricular fibrillation [VF]) detection and therapy for ICDs is complex, requires many choices by highly trained physicians, and directly influences the frequency of shocks and patient morbidity.
METHODS: A total of 900 ICD patients were randomly assigned to standardized (EMPIRIC, n = 445) or physician-tailored (TAILORED, n = 455) VT/VF programming and followed for 1 year.
RESULTS: The primary end point was met: the adjusted percentages of both VT/VF (22.3% vs. 28.7%) and supraventricular tachycardia or other non-VT/VF event episodes (11.9% vs. 26.1%) that resulted in a shock were non-inferior and lower in the EMPIRIC arm compared to the TAILORED arm. The time to first all-cause shock was non-inferior in the EMPIRIC arm (hazard ratio = 0.95, 90% confidence interval 0.74 to 1.23, non-inferiority p = 0.0016). The EMPIRIC trial had a significant reduction of patients with 5 or more shocks for all-cause (3.8% vs. 7.0%, p = 0.039) and true VT/VF (0.9% vs. 3.3%, p = 0.018). There were no significant differences in total mortality, syncope, emergency room visits, or unscheduled outpatient visits. Unscheduled hospitalizations occurred significantly less often (p = 0.001) in the EMPIRIC arm.
CONCLUSIONS: Standardized empiric ICD programming for VT/VF settings is at least as effective as patient-specific, physician-tailored programming, as measured by many clinical outcomes. Simplified and pre-specified ICD programming is possible without an increase in shock-related morbidity.

Entities:  

Mesh:

Year:  2006        PMID: 16843184     DOI: 10.1016/j.jacc.2006.03.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

Review 1.  Strategic choices to reduce implantable cardioverter-defibrillator-related morbidity.

Authors:  Oussama Wazni; Bruce L Wilkoff
Journal:  Nat Rev Cardiol       Date:  2010-04-20       Impact factor: 32.419

2.  Does the rate of inappropriate therapy differ in implantable cardioverter-defibrillators from different manufacturers?

Authors:  Arash Arya; Majid Haghjoo; Zahra Emkanjoo; Mohammad Reza Dehghani; Mohammad Ali Sadr-Ameli
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

3.  Device therapy: Defibrillators-a shocking therapy for cardiomyopathy?

Authors:  John G F Cleland; Laszlo Buga
Journal:  Nat Rev Cardiol       Date:  2010-02       Impact factor: 32.419

4.  Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.

Authors:  Jörg Otto Schwab; Hendrik Bonnemeier; Thomas Kleemann; Johannes Brachmann; Sven Fischer; Frank Birkenhauer; Frank Eberhardt
Journal:  Clin Res Cardiol       Date:  2015-05-23       Impact factor: 5.460

Review 5.  ICD programming to reduce shocks and improve outcomes.

Authors:  Valentina Kutyifa; Wojciech Zareba; Arthur J Moss
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

6.  Reduction of the inappropriate ICD therapies by implementing a new fuzzy logic-based diagnostic algorithm.

Authors:  Michał Lewandowski; Andrzej Przybylski; Wiesław Kuźmicz; Hanna Szwed
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09       Impact factor: 1.468

Review 7.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

Review 8.  Sensing and detection in Medtronic implantable cardioverter defibrillators.

Authors:  Mark L Brown; Charles D Swerdlow
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09-08

9.  A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study.

Authors:  Maurizio Gasparini; Carlo Menozzi; Alessandro Proclemer; Maurizio Landolina; Severio Iacopino; Angelo Carboni; Ernesto Lombardo; François Regoli; Mauro Biffi; Valeria Burrone; Alessandra Denaro; Giuseppe Boriani
Journal:  Eur Heart J       Date:  2009-06-29       Impact factor: 29.983

10.  Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results.

Authors:  Massimo Santini; Maurizio Lunati; Pascal Defaye; Johann Mermi; Alessandro Proclemer; Silvia del Castillo-Arroys; Giulio Molon; Elisabetta Santi; Tiziana De Santo; Xavier Navarro; Axel Kloppe
Journal:  J Interv Card Electrophysiol       Date:  2010-01-20       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.